financetom
Business
financetom
/
Business
/
Angel Broking believes millennials will stay invested in equity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Angel Broking believes millennials will stay invested in equity
Aug 3, 2021 7:09 AM

Angel Broking has unveiled a new brand identity called ‘Angel One’, which will help it connect with the Gen Z or millennials and try and expand their target group. Dinesh Thakkar, Chairman and MD of Angel Broking discussed the motivation for rebranding and the core target group the company is trying to address with this.

Share Market Live

NSE

“Our target audience remains millennials,” he said.

“India market is very underpenetrated and the trend that we are seeing of milennials coming to the market is secular and is here to stay,” he added.

“COVID accelerated this trend but it was unavoidable. When we are talking about India being young and people getting their first job, they don’t have any other alternative but to invest in equity as an asset class. So the trend we are seeing of participation from tier-II, tier-III and beyond, this access was never available to people,” he explained.

“By 2015-2016 we realized that India is much beyond just urban and tier-I and people like youth, millennial - very smartphone savvy – started using our mobile app to invest in market. That is where we digitized this whole thing to serve this group. Progressively, we have become more of a tech company. We thought that being a tech company we can offer a lot to end-customer, we can offer them solutions related to their personal finance,” he stated.

For the full interview, watch the accompanying video.

(Edited by : Aditi Gautam)

First Published:Aug 3, 2021 4:09 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cancer biotech firm Alterome Therapeutics raises $132 mln in Goldman Sachs-led round
Cancer biotech firm Alterome Therapeutics raises $132 mln in Goldman Sachs-led round
Apr 3, 2024
April 3 (Reuters) - Biotechnology firm Alterome Therapeutics said on Wednesday it has raised $132 million in a series B financing round, which was led by Goldman Sachs Alternatives. The series B financing, which brings its total funding to nearly $232 million to date, also saw participation by Canaan Partners, Driehaus Capital Management, Invus, Digitalis Ventures, Blue Owl Capital, and...
Digihost Technology Reports Loss for Q4, Revenue Grows; Provides Update
Digihost Technology Reports Loss for Q4, Revenue Grows; Provides Update
Apr 3, 2024
07:08 AM EDT, 04/03/2024 (MT Newswires) -- Digihost Technology Inc. ( DGHI ) , a US-based blockchain technology and computer infrastructure company, on Wednesday reported a fourth-quarter net loss of US$9.7 million, or US$0.34 per diluted share, as compared with a loss of US$9.7 million, or US$0.36 per diluted share, a year earlier. Revenue for the quarter ended Dec. 31,...
Hedge funds rally in Q1, powered by gains in equities
Hedge funds rally in Q1, powered by gains in equities
Apr 3, 2024
NEW YORK (Reuters) - Hedge funds capped the first quarter with gains across different strategies, as a rally in stocks, some commodities and the dollar helped the industry weather a less shiny period for bonds, investors said. Fundamental equities long/short hedge funds were up 6.28% in the first quarter, while systematic long/short funds posted gains of 11%, according to a...
Lenz Therapeutics' eye disease drugs meet main goal of late-stage study
Lenz Therapeutics' eye disease drugs meet main goal of late-stage study
Apr 3, 2024
April 3 (Reuters) - Lenz Therapeutics ( LENZ ) said on Wednesday its experimental drugs to treat loss of near vision met the main goal of a late-stage study. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved